MX9605048A - Gonadotropinas con puentes de disulfuros no nativos. - Google Patents

Gonadotropinas con puentes de disulfuros no nativos.

Info

Publication number
MX9605048A
MX9605048A MX9605048A MX9605048A MX9605048A MX 9605048 A MX9605048 A MX 9605048A MX 9605048 A MX9605048 A MX 9605048A MX 9605048 A MX9605048 A MX 9605048A MX 9605048 A MX9605048 A MX 9605048A
Authority
MX
Mexico
Prior art keywords
gonadothropines
disulfide bridges
non native
native disulfide
sub
Prior art date
Application number
MX9605048A
Other languages
English (en)
Other versions
MXPA96005048A (es
Inventor
Peter Diederik Jan Grootenhuis
Judith Christina Heikoop
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8220762&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9605048(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MX9605048A publication Critical patent/MX9605048A/es
Publication of MXPA96005048A publication Critical patent/MXPA96005048A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a las gonadotropinas que consisten en una subunidad y una subunidad, comprendiendo dichas gonadotropinas puentes de disulfuro no nativos, de preferencia puentes de disulfuro entre subunidades no nativos. Las gonadotropinas de acuerdo con la invencion tienen una estabilidad mejorada. La presente invencion además considera composiciones farmacéuticas que comprenden dichas gonadotropinas.
MXPA/A/1996/005048A 1995-10-24 1996-10-23 Gonadotropinas con puentes de disulfuros nonativos MXPA96005048A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL95202876.9 1995-10-24
EP95202876 1995-10-24

Publications (2)

Publication Number Publication Date
MX9605048A true MX9605048A (es) 1997-09-30
MXPA96005048A MXPA96005048A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
EP0785215A1 (en) 1997-07-23
JPH09176039A (ja) 1997-07-08
IL119412A0 (en) 1997-01-10
AR004088A1 (es) 1998-09-30
CN1161381C (zh) 2004-08-11
TR199600852A2 (tr) 1997-05-21
EP0785215B1 (en) 2002-06-05
ATE218584T1 (de) 2002-06-15
ES2177721T3 (es) 2002-12-16
KR970021096A (ko) 1997-05-28
RU2174407C2 (ru) 2001-10-10
CN1154371A (zh) 1997-07-16
IL119412A (en) 2000-07-26
HU222043B1 (hu) 2003-04-28
AU7037896A (en) 1997-05-01
BR9605220B1 (pt) 2010-10-19
DK0785215T3 (da) 2002-09-16
TR199600852A3 (es) 1997-05-21
CA2188508A1 (en) 1997-04-25
HU9602923D0 (en) 1996-12-30
DE69621577T2 (de) 2003-01-16
AU711081B2 (en) 1999-10-07
BR9605220A (pt) 1998-07-21
DE69621577D1 (de) 2002-07-11
US5691455A (en) 1997-11-25
CA2188508C (en) 2005-12-20
HUP9602923A1 (hu) 1999-02-01
KR100498532B1 (ko) 2005-10-06
JP4086922B2 (ja) 2008-05-14

Similar Documents

Publication Publication Date Title
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
IL149459A0 (en) Recombinant gelatins
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
HK1022251A1 (en) Novel use of native gellan gum.
BG103384A (en) Halogenpyrimidinylaryl (thio)ethers as pesticides
MY113022A (en) Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present
EP0656030A4 (en) STABILIZING SYSTEM FOR THE COMPOSITIONS OF THIOL-ENES AND THIOL-NENES.
EP0599532A3 (en) One-component crosslinkable organosiloxane compositions.
ZA968833B (en) Gelled near tricritical point compositions.
MA24643A1 (fr) Tetrahydro-naphtalenes substitues et composes analogues
BG103914A (en) Maintained separation of delayed gels
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
FR2712491B1 (fr) Compositions antisudorales.
EP0831871A4 (en) SIMILAR FACTOR TO RELAXIN, ITS METHODS AND USES
BG101892A (en) Sugar-modified cytostatics
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
WO2001034647A3 (en) Animal collagens and gelatins
WO1999017711A3 (en) Autophobic hairspray compositions
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
BG103306A (en) Liquid allendronate compositions
SE9602822D0 (sv) New receptor
IL139604A0 (en) Novel peptides